Covered recipient · General Payments record
MADELINE L JONES RYAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2020–2024
$2,589.02
- Reported across 170 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $235.17 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $52.14 | 3 |
| Amgen Inc. | $31.71 | 2 |
| Alexion Pharmaceuticals, Inc. | $25.51 | 1 |
| EISAI INC. | $19.65 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $17.70 | 1 |
| CHIESI USA, INC. | $15.95 | 1 |
| BETA BIONICS, INC. | $15.86 | 1 |
| Amneal Pharmaceuticals LLC | $15.34 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.88 | 1 |
| Ascensia Diabetes Care US Inc. | $13.22 | 1 |
| Novo Nordisk AS | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $25.51 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093955135 | CMS |
| Amgen Inc. | $14.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111611273 | CMS |
| Amgen Inc. | $17.28 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111611275 | CMS |
| Amneal Pharmaceuticals LLC | $15.34 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139190476 | CMS |
| Ascensia Diabetes Care Us Inc. | $13.22 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089088210 | CMS |
| BETA BIONICS, INC. | $15.86 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087874619 | CMS |
| Chiesi USA, Inc. | $15.95 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151809871 | CMS |
| Eisai Inc. | $19.65 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110761819 | CMS |
| Lilly USA, LLC | $15.60 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135144289 | CMS |
| Lilly USA, LLC | $20.91 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135142153 | CMS |
| Lilly USA, LLC | $15.63 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135161939 | CMS |
| Novo Nordisk Inc | $13.21 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096875391 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $17.70 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139163540 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.88 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139720262 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.